Aflibercept
Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. Reference standards of Aflibercept API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Aflibercept
[catalogue_number] => PA PEP 001167
[category_ids] => ,114,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => 862111-32-8
[pslug] => 862111-32-8-aflibercept-api-standards-papep001167
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
